Laser for retina and vitreous: all you need to know in 2023
Subthreshold laser: a new hope for macular degeneration?
Dr Lihteh Wu presents why Subthreshold laser can be consider as a new hope for macular degeneration.
Best practices in subthreshold laser treatment, which laser should be used and how?
Dr Kenneth Fong presents best practices in subthreshold laser treatment to easily understand which laser should be used and how.
Central Serous Chorioretinopathy: effectiveness and safety without verteporfin?
During 2022 EURETINA congress, Dr Alejandro Filloy explains how to treat CSC safely and effectively without verteporfin.
Retinal laser treatments in Covid 19 era: from PDR to DME
During 2022 EURETINA symposium, Dr Victor Chong presents the use of retinal laser treatments in COVID 19 era, from PDR to DME.
SubLiminal Laser Therapy: Concept and reasons
Dr Kenneth FONG presents SubLiminal Laser Therapy for macula diseases through the concepts and reasons, during APAO 2021
Macular Laser photocoagulation: Still relevant in 2021?
During the EURETINA symposium, Dr Victor Chong explains his ideas on Macular Laser Photocoagulation wondering if it is still relevant in 2021.
Anti-VEGF vs Laser for PDR, a changing treatment paradigm?
Dr Lihteh Wu talks about the controversies in laser treatment in 2021 during the EURETINA symposium.
Do We Still Need Subthreshold Laser for Macular Diseases?
On the occasion of the launch of the new society SOLS (Subthreshold Ophthalmic Laser Society), Dr. Kenneth Fong, Dr. Victor Chong, Dr. Lihteh Wu, Dr Jay Chhablani & Dr. Alejandro Filloy Rius discussed the use of Subthreshold Laser for Macular Diseases.
What is the role of Easyret subthreshold laser in macular diseases?
Dr Kenneth Fong reviews the role of Easyret® subthreshold laser for DME and CSR treatment. In this webinar (in English), he concludes that yellow subthreshold laser has more beneficial effect in visual acuity than half dose PDT.
Quantel Medical & Ellex, 2 brands of Lumibird Medical, united with 1 objective: develop cutting-edge technologies for the diagnosis and treatment of dry eye and leading causes of blindness worldwide: glaucoma, cataracts, AMD and diabetic retinopathy.